NCT06763965 2025-12-02
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
Clinical Trials
4 trialsNCT07126990 2025-09-23
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT06690216 2025-03-30
PD-L1-PET
Shandong Cancer Hospital and Institute
Phase 1/2 Enrolling by invitation
NCT01868490 2025-02-10
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells
Siriraj Hospital
Phase 1/2 Enrolling by invitation